[Skip to Navigation]
Invited Commentary
April 8, 2013

Glucagonlike Peptide 1–Based Drugs and Pancreatitis: Clarity at Last, but What About Pancreatic Cancer?Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”

Author Affiliations

Author Affiliations: Larry L. Hillblom Islet Research Center (Drs Gier and Butler) and Jonsson Comprehensive Cancer Center (Dr Butler), University of California, Los Angeles, David Geffen School of Medicine.

JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374
Add or change institution